322 related articles for article (PubMed ID: 16973579)
1. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
[TBL] [Abstract][Full Text] [Related]
2. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
Kutluay SB; Perez-Caballero D; Bieniasz PD
PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
[TBL] [Abstract][Full Text] [Related]
3. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.
Wu X; Anderson JL; Campbell EM; Joseph AM; Hope TJ
Proc Natl Acad Sci U S A; 2006 May; 103(19):7465-70. PubMed ID: 16648264
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
[TBL] [Abstract][Full Text] [Related]
6. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
8. Efficient transduction of human hematopoietic repopulating cells with a chimeric HIV1-based vector including SIV capsid.
Uchida N; Hsieh MM; Washington KN; Tisdale JF
Exp Hematol; 2013 Sep; 41(9):779-788.e1. PubMed ID: 23665451
[TBL] [Abstract][Full Text] [Related]
9. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
10. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
12. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.
Perez-Caballero D; Hatziioannou T; Zhang F; Cowan S; Bieniasz PD
J Virol; 2005 Dec; 79(24):15567-72. PubMed ID: 16306627
[TBL] [Abstract][Full Text] [Related]
13. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
Carthagena L; Parise MC; Ringeard M; Chelbi-Alix MK; Hazan U; Nisole S
Retrovirology; 2008 Jul; 5():59. PubMed ID: 18613956
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Burse M; Shi J; Aiken C
PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
[TBL] [Abstract][Full Text] [Related]
15. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.
Bérubé J; Bouchard A; Berthoux L
Retrovirology; 2007 Sep; 4():68. PubMed ID: 17892575
[TBL] [Abstract][Full Text] [Related]
16. TRIM5α and Species Tropism of HIV/SIV.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():13. PubMed ID: 22291694
[TBL] [Abstract][Full Text] [Related]
17. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
Campbell EM; Perez O; Anderson JL; Hope TJ
J Cell Biol; 2008 Feb; 180(3):549-61. PubMed ID: 18250195
[TBL] [Abstract][Full Text] [Related]
18. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
[TBL] [Abstract][Full Text] [Related]
19. TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling.
Lascano J; Uchil PD; Mothes W; Luban J
J Virol; 2016 Jan; 90(1):308-16. PubMed ID: 26468522
[TBL] [Abstract][Full Text] [Related]
20. Independent evolution of an antiviral TRIMCyp in rhesus macaques.
Wilson SJ; Webb BL; Ylinen LM; Verschoor E; Heeney JL; Towers GJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3557-62. PubMed ID: 18287035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]